Martin R Sprick

Dikutip oleh

	Semua	Sejak 2020
Kutipan	11245	3395
indeks-h	39	28
indeks-i10	55	44

820

410

205

615

200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202577 83 133 162 200 197 181 202 312 368 557 566 614 640 664 696 696 691 729 732 808 672 579 549 54

Akses publik

Lihat semua

32 artikel

4 artikel

tersedia

tidak tersedia

Berdasarkan pada mandat pendanaan

Pengarang bersama

Andreas TrumppHI-STEM & DKFZ, Heidelberg, GermanyEmail yang diverifikasi di hi-stem.de
jan paul medemaHoogleraar Exp Oncology and RadiobiologyEmail yang diverifikasi di amc.nl
Wilko WeichertInstitute of Pathology, Technical University Munich (TUM)Email yang diverifikasi di tum.de
Giorgio StassiFull Professor in Medical Laboratory Science and Technology. University of PalermoEmail yang diverifikasi di unipa.it
Louis Vermeulen MD PhDProfessor Molecular Oncology - Amsterdam University Medical Centers, University of AmsterdamEmail yang diverifikasi di amsterdamumc.nl
Albrecht Stenzinger, MDInstitute of Pathology, University Hospital Heidelberg, GermanyEmail yang diverifikasi di med.uni-heidelberg.de
Irene BaccelliEmail yang diverifikasi di umontreal.ca
Matilde TodaroUniversity Researcher, University of PalermoEmail yang diverifikasi di unipa.it
Anne Grosse-WildeSeattle GeneticsEmail yang diverifikasi di seagen.com
Massimo SainiUniversity of BaselEmail yang diverifikasi di unibas.ch
Roland EilsProfessor for Digital Health, Charité-Universitätsmedizin Berlin and Berlin Institute of HealthEmail yang diverifikasi di charite.de
JB TuynmanColorectal surgeon, MD, PhD, colorectal surgery, amsterdam UMC, surgical trainingEmail yang diverifikasi di amsterdamumc.nl
Matthias SchlesnerBiomedical Informatics, Data Mining and Data Analytics, Augsburg UniversityEmail yang diverifikasi di informatik.uni-augsburg.de
John BlenisProfessor of Pharmacology, Weill Cornell MedicineEmail yang diverifikasi di med.cornell.edu
Peter JuoTufts University School of MedicineEmail yang diverifikasi di tufts.edu
Sascha PahernikProfessor für UrologieEmail yang diverifikasi di klinikum-nuernberg.de
Matthias GoebelerUniversity of Würzburg, University of Heidelberg, University of Giessen, University of MünsterEmail yang diverifikasi di klinik.uni-wuerzburg.de
Strobel ODept of General Surgery, Medical University of ViennaEmail yang diverifikasi di meduniwien.ac.at
Joost VerhoeffProfessor of radiation oncology, Head of department at Amsterdam UMCEmail yang diverifikasi di drverhoeff.nl
Olaf van TellingenNetherlands Cancer InstituteEmail yang diverifikasi di nki.nl

Ikuti

Martin R Sprick

HI-STEM gGmbH, DKFZ-Heidelberg

Email yang diverifikasi di dkfz.de - Beranda

Cancer Stem Cells Pancreatic Cancer Renal Cancer Ovarian Cancer Caspases


Judul Urutkan menurut kutipan Urutkan menurut tahun Urutkan menurut judul	Dikutip oleh Dikutip oleh	Tahun
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment L Vermeulen, F De Sousa E Melo, M Van Der Heijden, K Cameron, ... Nature cell biology 12 (5), 468-476, 2010	2123	2010
Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay I Baccelli, A Schneeweiss, S Riethdorf, A Stenzinger, A Schillert, V Vogel, ... Nature biotechnology 31 (6), 539-544, 2013	1221	2013
FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2 MR Sprick, MA Weigand, E Rieser, CT Rauch, P Juo, J Blenis, ... Immunity 12 (6), 599-609, 2000	1042	2000
Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity L Vermeulen, M Todaro, F de Sousa Mello, MR Sprick, K Kemper, ... Proceedings of the National Academy of Sciences 105 (36), 13427-13432, 2008	931	2008
Caspase‐10 is recruited to and activated at the native TRAIL and CD95 death‐inducing signalling complexes in a FADD‐dependent manner but can not functionally substitute caspase‐8 MR Sprick, E Rieser, H Stahl, A Grosse‐Wilde, MA Weigand, H Walczak The EMBO journal, 2002	529	2002
Cancer stem cells–old concepts, new insights L Vermeulen, MR Sprick, K Kemper, G Stassi, JP Medema Cell Death & Differentiation 15 (6), 947-958, 2008	468	2008
The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation K Kemper, MR Sprick, M de Bree, A Scopelliti, L Vermeulen, M Hoek, ... Cancer research 70 (2), 719-729, 2010	467	2010
The interplay between the Bcl-2 family and death receptor-mediated apoptosis MR Sprick, H Walczak Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1644 (2-3), 125-132, 2004	341	2004
Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by … TM Ganten, TL Haas, J Sykora, H Stahl, MR Sprick, SC Fas, A Krueger, ... Cell Death & Differentiation 11 (1), S86-S96, 2004	258	2004
CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma EM Noll, C Eisen, A Stenzinger, E Espinet, A Muckenhuber, C Klein, ... Nature medicine 22 (3), 278-287, 2016	231	2016
Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations J Jabs, FM Zickgraf, J Park, S Wagner, X Jiang, K Jechow, K Kleinheinz, ... Molecular systems biology 13 (11), 955, 2017	217	2017
Survival of pancreatic cancer cells lacking KRAS function MD Muzumdar, PY Chen, KJ Dorans, KM Chung, A Bhutkar, E Hong, ... Nature communications 8 (1), 1090, 2017	180	2017
Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumors M Djurec, O Graña, A Lee, K Troulé, E Espinet, L Cabras, C Navas, ... Proceedings of the National Academy of Sciences 115 (6), E1147-E1156, 2018	175	2018
Oncogenic K-Ras turns death receptors into metastasis-promoting receptors in human and mouse colorectal cancer cells FJH Hoogwater, MW Nijkamp, N Smakman, EJA Steller, BL Emmink, ... Gastroenterology 138 (7), 2357-2367, 2010	174	2010
TNF-related apoptosis-inducing ligand mediates tumoricidal activity of human monocytes stimulated by Newcastle disease virus B Washburn, MA Weigand, A Grosse-Wilde, M Janke, H Stahl, E Rieser, ... The Journal of Immunology 170 (4), 1814-1821, 2003	155	2003
Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL-and CD95L-mediated apoptosis P Geserick, C Drewniok, M Hupe, TL Haas, P Diessenbacher, MR Sprick, ... Oncogene 27 (22), 3211-3220, 2008	152	2008
Proteasome Inhibition Results in TRAIL Sensitization of Primary Keratinocytes by Removing the Resistance-Mediating Block of Effector Caspase Maturation M Leverkus, MR Sprick, T Wachter, T Mengling, B Baumann, E Serfling, ... Molecular and Cellular Biology 23 (3), 777-790, 2003	147	2003
TRAIL/bortezomib cotreatment is potentially hepatotoxic but induces cancer‐specific apoptosis within a therapeutic window R Koschny, TM Ganten, J Sykora, TL Haas, MR Sprick, A Kolb, ... Hepatology 45 (3), 649-658, 2007	145	2007
A synergistic interaction between Chk1-and MK2 inhibitors in KRAS-mutant cancer F Dietlein, B Kalb, M Jokic, EM Noll, A Strong, L Tharun, L Ozretić, ... Cell 162 (1), 146-159, 2015	142	2015
The linear ubiquitin chain assembly complex regulates TRAIL‐induced gene activation and cell death E Lafont, C Kantari‐Mimoun, P Draber, D De Miguel, T Hartwig, ... The EMBO journal 36 (9), 1147-1166, 2017	137	2017

Sistem tidak dapat melakukan operasi ini. Coba lagi nanti.

Artikel 1–20

Kutipan per tahun

Kutipan duplikat

Kutipan yang digabung

Tambahkan pengarang bersamaPengarang bersama

Ikuti

Dikutip oleh

Pengarang bersama